PR Newswire Consumer
prCenter
AARD Shareholder Alert: October 13, 2026 Lead Plaintiff Deadline in Aardvark Therapeutics, Inc. Securities Class Action - Contact SueWallSttranslating…
A securities class action alleges former Chief Operating Officer Bryan Jones, Ph.D. told investors in May 2025 that ARD-101 had a "very, very clean" safety profile, months before cardiac observations allegedly forced a Phase 3 pause and a full FDA clinical hold. NEW YORK, Sept…
Keywords#Class Action#Securities Class#AARD#AARD Shareholder#AARD Shareholder Alert
Comments
Sign in to join the discussion.
Loading comments…